|
|||||
|
|
Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion‐associated graft‐versus‐host disease |
|
| Authors: | Grace Castro Patricia A. Merkel Hannah E. Giclas Andrew Gibula Gillian E. Andersen Laurence M. Corash Jin Sying Lin Jennifer Green Vijaya Knight Adonis Stassinopoulos |
| Affiliation: | 1. Cerus Corporation, Concord, California;2. National Jewish Health, Denver, Colorado |
| Abstract: | |
| Keywords: | |